Solid Tumor Pediatric
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Tremelimumab for Pediatric Malignancies (NCT03837899) | AstraZeneca | 2019-03-07 |
Track Solid Tumor Pediatric automatically
Every clearance here is in the API, with alerts when new ones post.